Inflammatix, Inc.

Sunnyvale, CA Doing business as Inflammatix Inc.

UEI
WK9MLMSHBVL3
CAGE
7Q4D9
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
540 Oakmead Pkwy, Sunnyvale, CA 94085, USA
Website
inflammatix.com
Founded
2016
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Inflammatix, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of a multi-RNA signature in blood towards a rapid diagnostic test to robustly distinguish patients with… Grant · R43HL167483 National Heart Lung and Blood Institute $299,762
Inflammatix, INC. R & d for triverity cartridge development AOI #2 (infection severity and solving sepsis) Contract · 75A50122C00069 Office of the Assistant Secretary for Preparedness and Response $749,999
Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes - abstract sepsis, a… Grant · R44GM142428 National Institute of General Medical Sciences $4,087,564
Development of baseline gene expression-based response predictor for anti-tnfa therapy in patients with inflammatory… Grant · R43DK127578 National Institute of Diabetes and Digestive and Kidney Diseases $754,113
Hostdxtm-covid severity: a host-response prognostic tool for covid-19 and other viral pandemics Contract · HR00112090121 Defense Advanced Research Projects Agency $453,851

About Inflammatix, Inc.

Written by GovTribe AI ·

Inflammatix, Inc. is a molecular diagnostics company that develops rapid point of care diagnostic tests by analyzing the immune system to address major clinical health challenges. Through federal contracts and grants, Inflammatix provides research, development, and testing services related to diagnostic solutions for acute infections and sepsis.

Inflammatix has been awarded over $29 million in federal contracts from the Department of Health and Human Services to support the development of diagnostic cartridges and host-response prognostic tools. This includes contracts to develop the Triverity cartridge for detecting infection severity and a host-response test called HOSTDX-Sepsis. Additional federal contracts have supported Inflammatix's development of solutions for COVID-19 diagnostics and therapeutics.

Through federal grants, Inflammatix conducts research on diagnostic tests for conditions such as sepsis, myocardial infarction, and inflammatory bowel disease. A $4 million National Institutes of Health grant is funding validation and development of a rapid blood test to classify sepsis patients into subgroups for improved treatment plans. Another NIH grant supported development of a gene expression test to predict response to anti-TNF therapies for inflammatory bowel disease. Inflammatix leverages machine learning and meta-analysis approaches in developing these novel diagnostic solutions.

Quick answers

What is Inflammatix, Inc.'s UEI?

Inflammatix, Inc.'s Unique Entity ID (UEI) in SAM.gov is WK9MLMSHBVL3.

What is Inflammatix, Inc.'s CAGE code?

Inflammatix, Inc.'s CAGE code is 7Q4D9.

What is Inflammatix, Inc.'s primary NAICS code?

Inflammatix, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Inflammatix, Inc. located?

Inflammatix, Inc.'s physical address in SAM.gov is 540 Oakmead Pkwy, Sunnyvale, CA 94085, USA.

Is Inflammatix, Inc. registered in SAM.gov?

Yes. Inflammatix, Inc.'s SAM.gov registration is active through April 9, 2027.

What is Inflammatix, Inc.'s most recent federal award?

Inflammatix, Inc.'s most recent federal grant award is Development of a multi-RNA signature in blood towards a rapid diagnostic test to robustly distinguish patients with… (R43HL167483), from National Heart Lung and Blood Institute, on July 1, 2023.

On GovTribe

See Inflammatix, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login